Successful treatment of primary cutaneous localized amyloidosis with a combined therapy of ablative fractionated CO2 laser, topical retinoid, corticosteroids and levovitamin C: Five cases with two-year follow-up

Yao-Jia Luo; Xing-Hua Gao; Hong-Duo Chen; Yuan-Hong Li

doi:10.1080/14764172.2017.1307412

Successful treatment of primary cutaneous localized amyloidosis with a combined therapy of ablative fractionated CO₂ laser, topical retinoid, corticosteroids and levovitamin C: Five cases with two-year follow-up

J Cosmet Laser Ther. 2021 Feb 17;23(1-2):16-18. doi: 10.1080/14764172.2017.1307412. Epub 2021 Jul 27.

Authors

Yao-Jia Luo¹, Xing-Hua Gao¹, Hong-Duo Chen¹, Yuan-Hong Li¹

Affiliation

¹ Department of Dermatology, No.1 Hospital of China Medical University, Shenyang, Liaoning, China.

PMID: 28426270
DOI: 10.1080/14764172.2017.1307412

Abstract

Primary cutaneous localized amyloidosis (PCLA) is a pruritic disorder with no radical cure. We trialed a combined therapy of ablative fractionated CO2 laser, topical retinoid, corticosteroids and levovitamin C on five patients. All patients responded with no intolerant signs. Two-year follow-up visit showed no recurrence. This might be a effective method awaiting more samples for further stronger evidence.

Keywords: Primary cutaneous localized amyloidosis; ablative laser; combined therapy.

MeSH terms

Adrenal Cortex Hormones
Amyloidosis, Familial*
Carbon Dioxide
Follow-Up Studies
Humans
Laser Therapy*
Lasers, Gas* / therapeutic use
Retinoids

Substances

Adrenal Cortex Hormones
Retinoids
Carbon Dioxide